From left: Dr Allan Njau, Consultant Anatomic and Molecular Pathologist, Dr Affrin Shaffi, and Dr Njoki Njiraini during the AstraZeneca BRCA testing launch in Nairobi, November 28, 2025. [Ryan Kerubo, Standard]
Testing for changes in breast cancer genes that can be inherited and greatly increase a person’s risk of getting certain cancers, has long been out of reach for many Kenyans due to cost and limited diagnostic infrastructure.